A federal appeals court cleared the way for drug manufacturer Purdue Pharma to settle thousands of lawsuits regarding its role in fueling the opioid epidemic in the U.S., reinstating a bankruptcy settlement that controversially shields from future claims.
The U.S. Court of Appeals for the Second Circuit greenlit a plan in which the Sackler family will pay up to $6 billion in settlement money to help ease the opioid crisis, while relinquishing control of the company. In the mid-1990s and early 2000s, the company manufactured and aggressively marketed OxyContin, the potent — and lucrative — opioid painkiller that helped spark the nation’s unprecedented addiction crisis.
tallying tens of billions of dollars — money that local and state governments are supposed to use to fight addiction and save lives.Following the lawsuits, Purdue Pharma filed for bankruptcy in 2019, while members of the Sackler family did not. In September 2021, New York U.S. Bankruptcy Judge Robert D.
“Our settlement was both significant and imperfect — there will never be enough justice to match the depths of pain and suffering the Sackler family caused,” Connecticut Attorney General William Tong said in a statement Tuesday.
Edward Neiger, an attorney who represents relatives of victims who could get payouts under the deal, called Tuesday’s decision a “milestone.” He urged DOJ not to appeal; the settlement includes $750 million for relatives of victims.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Purdue Pharma can protect Sackler owners in opioid bankruptcy, court rulesBankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company's broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday.
Consulte Mais informação »
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsA federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma’s settlement of thousands of legal claims over the toll of opioids.
Consulte Mais informação »
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsRuling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits Sackler family members have been clear: If they don’t get the legal protections, they won’t do their part of the deal
Consulte Mais informação »
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsA federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids
Consulte Mais informação »
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsA federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma’s settlement of thousands of legal claims over the toll of opioids.
Consulte Mais informação »
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsA federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in New York on Tuesday overturned a lower court’s 2021 ruling that found bankruptcy courts did not have the authority to protect members of the Sackler family who own the company and who have not filed for bankruptcy protection from lawsuits. The concept is at the heart of Purdue’s plan to settle thousands of lawsuits in a deal that would include $5.5 billion to $6 billion from Sackler family members.
Consulte Mais informação »